{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-25-139161","form_type":"8-K","ticker":"FTRE","cik":"0001965040","company_name":"Fortrea Holdings Inc.","filed_at":"2025-06-11T23:59:59+00:00","discovered_at":"2026-05-14T18:02:50.587392+00:00","generated_at":"2026-05-19T14:14:34.656585+00:00","sec_items":["5.02","7.01","9.01"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"Fortrea names Anshul Thakral as permanent CEO effective August 4, 2025","bullets":["Anshul Thakral appointed President and CEO, effective August 4, 2025; replaces interim CEO Peter Neupert who remains chairman.","Thakral has over 20 years experience in CRO, pharma, and biotech; Co-founder/CEO of Launch Therapeutics since 2022.","Offer letter includes $1.1M base salary, 150% target bonus, and inducement equity grants of ~$12.5M (RSUs+PSAs) tied to performance.","Thakral also appointed Class III director; his term expires at 2026 annual meeting.","Severance plan amended to include CEO; equity grants outside 2023 Omnibus Incentive Plan (Nasdaq inducement exception)."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-25-139161","json":"https://secwatch.observer/filing/0001193125-25-139161.json","markdown":"https://secwatch.observer/filing/0001193125-25-139161.md","text":"https://secwatch.observer/filing/0001193125-25-139161.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1965040/000119312525139161/0001193125-25-139161-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1965040/000119312525139161/d55989d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-19T14:14:34.656585+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"398d0e5730","claim":"Peter M. Neupert departed as Interim Chief Executive Officer at Fortrea Holdings Inc..","evidence_excerpt":"Mr. Thakral will replace Peter M. Neupert, who has served as Interim Chief Executive Officer since May 13, 2025, although Mr. Neupert will continue to serve as a director of the Company and Chairman of the Board.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1965040/000119312525139161/0001193125-25-139161-index.htm","confidence":1.0,"family_label":"Executive change","details":[{"label":"Action","value":"replaced"},{"label":"Role","value":"Interim Chief Executive Officer"}],"fact_type":"executive_change"},{"claim_id":"52f31c69e9","claim":"Anshul Thakral was appointed as Class III Director at Fortrea Holdings Inc..","evidence_excerpt":"the Board also appointed Mr. Thakral as a Class III director, effective as of the Effective Date","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1965040/000119312525139161/0001193125-25-139161-index.htm","confidence":1.0,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Class III Director"}],"fact_type":"executive_change"},{"claim_id":"fa843028b9","claim":"Anshul Thakral was appointed as President and Chief Executive Officer at Fortrea Holdings Inc..","evidence_excerpt":"the Board of Directors of the Company (the “Board”) has appointed Anshul Thakral as President and Chief Executive Officer of the Company, effective upon his start date with the Company on August 4, 2025","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1965040/000119312525139161/0001193125-25-139161-index.htm","confidence":1.0,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"President and Chief Executive Officer"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}